IDEXX Laboratories, Inc.

NasdaqGS:IDXX Stock Report

Market Cap: US$33.8b

IDEXX Laboratories Future Growth

Future criteria checks 2/6

IDEXX Laboratories is forecast to grow earnings and revenue by 10.3% and 7.8% per annum respectively. EPS is expected to grow by 11.1% per annum. Return on equity is forecast to be 34.2% in 3 years.

Key information

10.3%

Earnings growth rate

11.1%

EPS growth rate

Medical Equipment earnings growth17.0%
Revenue growth rate7.8%
Future return on equity34.2%
Analyst coverage

Good

Last updated17 Dec 2024

Recent future growth updates

IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 03
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

At US$420, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List?

Nov 19
At US$420, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List?

IDEXX Laboratories Q3: Weak End-Market Demand Continues

Nov 11

Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects

Oct 28
Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects

Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

Oct 15
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

Sep 18
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease

A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Sep 05
A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?

Aug 20
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?

IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits

Aug 12

A Look Into IDEXX Laboratories' (NASDAQ:IDXX) Impressive Returns On Capital

Jul 02
A Look Into IDEXX Laboratories' (NASDAQ:IDXX) Impressive Returns On Capital

Looking For Fast Growth In Healthcare? IDEXX Has You Covered

Jun 28

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Jun 04
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?

May 21
Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?

IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

May 03
IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You

Apr 27
What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You

IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

Apr 11
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet

IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)

Apr 08

Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

Jan 30
Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?

IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified

Jan 16

Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

Jan 15
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

Dec 31
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit

IDEXX Laboratories: Outstanding Business, But Valuation Is Key

Aug 15

IDEXX Laboratories Stock Is Very Expensive

Aug 08

IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M

Aug 02

Earnings and Revenue Growth Forecasts

NasdaqGS:IDXX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,5291,1041,0621,21410
12/31/20254,1639859801,11112
12/31/20243,8838758701,08411
9/30/20243,845866793917N/A
6/30/20243,785846839969N/A
3/31/20243,725867797921N/A
12/31/20233,661845773907N/A
9/30/20233,588823680830N/A
6/30/20233,514791593747N/A
3/31/20233,431699456612N/A
12/31/20223,367679384543N/A
9/30/20223,340670438580N/A
6/30/20223,309664429578N/A
3/31/20223,274735605746N/A
12/31/20213,215745636756N/A
9/30/20213,135757663765N/A
6/30/20213,047728694770N/A
3/31/20212,858674666745N/A
12/31/20202,707582540648N/A
9/30/20202,591497445585N/A
6/30/20202,475460366524N/A
3/31/20202,457437286453N/A
12/31/20192,407428304459N/A
9/30/20192,351423290439N/A
6/30/20192,291407274418N/A
3/31/20192,252390262400N/A
12/31/20182,213377277400N/A
9/30/20182,170330280386N/A
6/30/20182,117307N/A386N/A
3/31/20182,045284N/A377N/A
12/31/20171,969263N/A373N/A
9/30/20171,906277N/A353N/A
6/30/20171,862263N/A343N/A
3/31/20171,820245N/A343N/A
12/31/20161,775222N/A339N/A
9/30/20161,732214N/A312N/A
6/30/20161,690202N/A289N/A
3/31/20161,637192N/A258N/A
12/31/20151,602192N/A222N/A
9/30/20151,554174N/A170N/A
6/30/20151,531182N/A186N/A
3/31/20151,508182N/A188N/A
12/31/20141,486182N/A236N/A
9/30/20141,488199N/A274N/A
6/30/20141,443193N/A259N/A
3/31/20141,405190N/A258N/A
12/31/20131,377188N/A246N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IDXX's forecast earnings growth (10.3% per year) is above the savings rate (2.6%).

Earnings vs Market: IDXX's earnings (10.3% per year) are forecast to grow slower than the US market (15.2% per year).

High Growth Earnings: IDXX's earnings are forecast to grow, but not significantly.

Revenue vs Market: IDXX's revenue (7.8% per year) is forecast to grow slower than the US market (9.1% per year).

High Growth Revenue: IDXX's revenue (7.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: IDXX's Return on Equity is forecast to be high in 3 years time (34.2%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 02:03
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IDEXX Laboratories, Inc. is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Ishan MajumdarBaptista Research
Balaji PrasadBarclays